QIA.DE
Price:
$39.94
Market Cap:
$9.67B
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for p...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
1998-07-22
Stock Exchange
XETRA
Ticker
QIA.DE
According to Qiagen N.V.’s latest financial reports and current stock price. The company's current PE Ratio is 124.81. This represents a change of 594.97% compared to the average of 17.96 of the last 4 quarters.
The mean historical PE Ratio of Qiagen N.V. over the last ten years is 47.66. The current 124.81 PE Ratio has changed 26.09% with respect to the historical average. Over the past ten years (40 quarters), QIA.DE's PE Ratio was at its highest in in the September 2020 quarter at 180.99. The PE Ratio was at its lowest in in the December 2017 quarter at -45.81.
Average
47.66
Median
44.99
Minimum
-186.98
Maximum
181.27
Discovering the peaks and valleys of Qiagen N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 106.65%
Maximum Annual PE Ratio = 181.27
Minimum Annual Increase = -547.33%
Minimum Annual PE Ratio = -186.98
Year | PE Ratio | Change |
---|---|---|
2023 | 29.07 | 7.48% |
2022 | 27.04 | 9.03% |
2021 | 24.81 | -85.41% |
2020 | 170.02 | -190.93% |
2019 | -186.98 | -547.33% |
2018 | 41.80 | -76.94% |
2017 | 181.27 | 106.65% |
2016 | 87.72 | 63.47% |
2015 | 53.66 | 11.38% |
2014 | 48.18 | -40.88% |
The current PE Ratio of Qiagen N.V. (QIA.DE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
26.97
5-year avg
12.79
10-year avg
47.66
Qiagen N.V.’s PE Ratio is greater than MorphoSys AG (-5.50), greater than Symrise AG (39.18), less than United Internet AG (128.66), greater than Brenntag SE (14.53), greater than Evotec SE (-8.83),
Company | PE Ratio | Market cap |
---|---|---|
-5.50 | $2.53B | |
39.18 | $15.35B | |
128.66 | $3.30B | |
14.53 | $8.75B | |
-8.83 | $1.51B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Qiagen N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Qiagen N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Qiagen N.V.'s PE Ratio?
How is the PE Ratio calculated for Qiagen N.V. (QIA.DE)?
What is the highest PE Ratio for Qiagen N.V. (QIA.DE)?
What is the 3-year average PE Ratio for Qiagen N.V. (QIA.DE)?
What is the 5-year average PE Ratio for Qiagen N.V. (QIA.DE)?
How does the current PE Ratio for Qiagen N.V. (QIA.DE) compare to its historical average?